Indegene is a digital-first, life sciences commercialization company. It helps biopharmaceutical, emerging biotech, and medical technology companies develop products, get them to market, and grow their impact through the life cycle in a more effective, efficient, and modern way. Indegene brings together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These include drug discovery and development, clinical trials, regulatory affairs, pharmacovigilance, medical affairs, and marketing & sales operations.
The Bangalore headquarters serves as the central hub for global operations, product development, technology innovation, and corporate strategy. It houses a significant portion of Indegene's delivery and R&D teams.
Located within Manyata Embassy Business Park, one of India's largest and most well-equipped tech parks, offering modern infrastructure, amenities, and a collaborative environment.
The work culture at Indegene's HQ is characterized by innovation, collaboration, and a fast-paced environment driven by the dynamic life sciences industry. There's a strong emphasis on learning, client-centricity, and leveraging technology to solve complex healthcare challenges.
The Bangalore HQ is strategically important due to its access to a large pool of skilled talent in technology, analytics, and life sciences, enabling Indegene to scale its global service delivery.
Indegene supports life sciences companies globally with a comprehensive suite of functions. These include R&D and clinical operations optimization, regulatory and safety services, medical affairs transformation, commercial and marketing strategy, digital engagement solutions, data analytics, and enterprise technology platforms. Their global delivery model leverages talent and expertise from various regions to serve clients worldwide.
Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Outer Ring Road, Nagawara
Bengaluru (Bangalore)
Karnataka
India
Address: 100 College Road West, Suite 100, Princeton, NJ 08540, USA
Strategic location to serve the dense cluster of life sciences companies on the US East Coast, providing local support and market expertise.
Address: The Record Hall, 16-16A Baldwins Gardens, London, EC1N 7RJ, UK
Provides a strong foothold in the European life sciences market, facilitating engagement with regional headquarters of global pharma companies and adherence to European regulatory standards.
Address: Unit 901, 9/F, Platinum, 233 Taicang Road, Huangpu District, Shanghai 200020, China
Addresses the unique needs and rapid growth of the Chinese pharmaceutical and healthcare market, navigating local regulations and cultural nuances.
Address: 100 King Street West, Suite 5600, Toronto, ON M5X 1C9, Canada
Provides localized support and expertise for the Canadian life sciences market, including navigating its specific regulatory and healthcare system requirements.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Indegy' leadership includes:
Indegy has been backed by several prominent investors over the years, including:
Indegene has focused on strengthening its board, particularly with the appointment of independent directors in the lead-up to its IPO in May 2024. No major C-suite departures have been publicly announced, indicating stability in the core leadership team.
Discover the tools Indegy uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Indegene commonly uses email formats such as [first].[last]@indegene.com or [first_initial][last]@indegene.com. These are standard patterns for corporate communications.
[first].[last]@indegene.com, [first_initial][last]@indegene.com
Format
john.doe@indegene.com, jdoe@indegene.com
Example
80%
Success rate
The Economic Times • May 13, 2024
Indegene Ltd. made a strong market debut with its shares listing at a 46% premium on the BSE at ₹659.70, compared to the issue price of ₹452. The IPO was oversubscribed 70 times, reflecting high investor demand....more
Business Standard • May 28, 2024
Indegene reported a consolidated net profit of Rs 38.9 crore for the quarter ended March 2024. Revenue from operations saw an 8.7% year-on-year increase to Rs 673.3 crore for the same period....more
Indegene Press Release / PR Newswire • February 7, 2024
Indegene announced its position as a 'Leader' in the IDC MarketScape report for Worldwide Life Science R&D Pharmacovigilance Services. This recognition highlights Indegene's capabilities in drug safety and risk management solutions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Indegy, are just a search away.